Loss of Depotentiation in Focal Dystonia
- Conditions
- Focal DystoniaHealthy Volunteers
- Interventions
- Other: PAS25Other: PAS10Other: PAS25-cTBS150
- Registration Number
- NCT03206112
- Brief Summary
Background
Focal dystonia is a brain disorder. It affects a muscle or muscles in a specific part of the body. Researchers think it may be related to excessive training or practice. They want to know more about how much training might trigger focal dystonia.
Objectives:
To study why people develop focal dystonia. To study how brain plasticity changes with focal dystonia.
Eligibility:
People at least 18 years of age with focal dystonia.
Healthy volunteers the same age are also needed.
Design:
Participants will be screened with a physical exam and questions. They may have blood and urine tests.
Participants will have up to 3 testing visits.
Participants will have small electrodes stuck on the skin on the hands or arms. Muscle activity will be recorded.
Participants will have transcranial magnetic stimulation (TMS). A wire coil will be placed onto the scalp. A brief electrical current will pass through the coil. The current will create a magnetic field that affects brain activity.
Participants may be asked to tense certain muscles or do simple actions during TMS.
A nerve at the wrist will get weak electrical stimulation. The stimulation may be paired with TMS for very short times.
Participants will receive repeated magnetic pulses. Participants will receive a total of 150 pulses during a 10-second period. An entire testing visit will last about 3 hours.
...
- Detailed Description
Objectives
Simulation paradigms can induce plastic changes in brain excitability. Paired associative stimulation (PAS) with an interstimulus interval of 25 ms (PAS25) induces a long-term potentiation (LTP)-like effect while that at an interval of 10 ms (PAS10) induces a long-term depression (LTD)-like effect. The LTP-like effect induced by PAS25 is exaggerated in patients with focal dystonia. The LTD-like effect with PAS10 is also increased in focal dystonia but not in the target area of PAS. Depotentiation refers to the reversal of LTP by which LTP is abolished by a following procedure that has no effect when it is given alone. Brain-derived neurotrophic factor has a variety of roles in modulating both LTP and LTD. The Val66Met single nucleotide polymorphism is related to abnormal cortical plasticity. In this protocol, we propose a study to test the hypothesis that depotentiation is weaker in focal dystonia patients compared to healthy controls. In addition, motor cortical inhibition is decreased in focal dystonia. We will test the changes in motor cortical inhibition following different interventional procedures in focal dystonia. We will also test the relationship between depotentiation and LTP/LTD-like effects in focal dystonia patients.
Study population
We intend to study up to 20 patients with focal dystonia and 20 age-matched healthy volunteers. Subjects will complete up to 3 study visits involving 3 different interventional procedures. Various outcome measures will be performed during each study visit.
Design
This is a hypothesis-driven study. We will compare the depotentiation effect in patients with focal dystonia to that in healthy volunteers. Patients will be evaluated with a clinical rating scale during the screening visit. Three interventional procedures will be tested during three study visits. Specifically, PAS25-cTBS150 tests the primary hypothesis with a depotentiation effect. PAS25 tests LTP-like effect and PAS10 tests the LTD-like effect. We will investigate the difference in outcome measures between patients and healthy volunteers after the interventional procedures. We will perform genetic tests to identify the brain-derived neurotrophic factor genotype in the patients and healthy volunteers.
Outcome measures
The primary outcome measure is motor-evoked potential (MEP) induced by transcranial magnetic stimulation immediately after the interventional procedure of PAS25-cTBS150. We will compare MEP amplitude in patients with that in healthy volunteers to identify whether depotentiation is weaker in focal dystonia. The secondary outcome measures are MEP amplitudes at other time points after the PAS25-cTBS150 procedure. We will also perform exploratory studies to investigate the effects of interventional procedures of PAS25 and PAS10 alone. We will test the relationship between depotentiation and LTP/LTD-like effects in focal dystonia. We will also study other exploratory outcome measures such as: resting and active motor threshold, MEP recruitment curve, excitability of motor cortical circuits (short- and long-interval intracortical inhibition, and intracortical facilitation) after three different interventional procedures.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 6
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Focal Dystonia PAS10 Subjects diagnosed with Focal Dystonia Healthy Volunteers PAS25 Healthy Volunteers Focal Dystonia PAS25 Subjects diagnosed with Focal Dystonia Focal Dystonia PAS25-cTBS150 Subjects diagnosed with Focal Dystonia Healthy Volunteers PAS10 Healthy Volunteers Healthy Volunteers PAS25-cTBS150 Healthy Volunteers
- Primary Outcome Measures
Name Time Method MEP amplitude immediately after the PAS25-cTBS150 (depotentiation) protocol throughout compare MEP amplitude in patients with that in healthy volunteers to identify whether depotentiation is weaker in focal dystonia
- Secondary Outcome Measures
Name Time Method MEP amplitudes throughout MEP amplitudes at other time points after the PAS25-cTBS150 procedure
Trial Locations
- Locations (1)
National Institutes of Health Clinical Center
🇺🇸Bethesda, Maryland, United States